Phase 4 Peripheral Arterial Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged between 18 and 65 years old
- People who have been diagnosed with a condition called atherosclerotic peripheral arterial disease (a narrowing or blockage of the arteries in the limbs due to fatty deposits)
- People for whom surgery or a procedure to restore blood flow to the affected area is not an option, or where such treatment has already been tried and has not worked
- People who have at least one wound or ulcer on the affected area that measures between 0.5 and 10 square centimetres in size
- People whose blood flow measurements in the lower limbs fall below a certain level, as measured by specific tests (confirm with trial site for exact measurement details)
- People who are willing and able to give informed consent and agree to follow all study procedures and attend follow-up appointments
Who may not be able to join:
- People who have been diagnosed with a specific blood vessel disease called Buerger's disease, as identified by a particular set of medical criteria
- People who are still considered suitable candidates for surgery or a procedure to restore blood flow
- People who have taken part in another stem cell study or received stem cell therapy within the past 3 months
- People who the trial doctors consider unsuitable to participate for any other reason (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Hanafiah Harunarashid, MS, National University of Malaysia
Phone: +60176073103
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in ischemic rest pain; Change in size of the ulcer; Change in ankle brachial pressure index (ABPI); Change in total walking distance; Change in major amputation-free survival; Change in angiogenesis
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.